<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Stat Med</journal-id><journal-id journal-id-type="iso-abbrev">Stat Med</journal-id><journal-id journal-id-type="publisher-id">sim</journal-id><journal-title-group><journal-title>Statistics in Medicine</journal-title></journal-title-group><issn pub-type="ppub">0277-6715</issn><issn pub-type="epub">1097-0258</issn><publisher><publisher-name>Blackwell Publishing Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">22763807</article-id><article-id pub-id-type="pmc">3588596</article-id><article-id pub-id-type="doi">10.1002/sim.5448</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Articles</subject></subj-group></article-categories><title-group><article-title>Dynamic randomization and a randomization model for clinical trials
data</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kaiser</surname><given-names>Lee D</given-names></name><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="corresp" rid="cor2">&#x02020;</xref></contrib><aff><institution>Genentech, Inc.</institution><addr-line>1 DNA Way, South San Francisco, 94080, CA, U.S.A.</addr-line></aff></contrib-group><author-notes><corresp id="cor1">*Correspondence to: Lee D. Kaiser, Genentech, Inc., 1 DNA
Way, South San Francisco 94080, CA, U.S.A.</corresp><corresp id="cor2">&#x02020; E-mail: <email>lkaiser@gene.com</email></corresp><fn><p>Re-use of this article is permitted in accordance with the Terms and
Conditions set out at <ext-link ext-link-type="uri" xlink:href="http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms">http://wileyonlinelibrary.com/onlineopen#OnlineOpen_Terms</ext-link></p></fn></author-notes><pub-date pub-type="ppub"><day>20</day><month>12</month><year>2012</year></pub-date><pub-date pub-type="epub"><day>05</day><month>7</month><year>2012</year></pub-date><volume>31</volume><issue>29</issue><fpage>3858</fpage><lpage>3873</lpage><history><date date-type="received"><day>03</day><month>8</month><year>2011</year></date><date date-type="accepted"><day>02</day><month>5</month><year>2012</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2012 John Wiley &#x00026; Sons,
Ltd.</copyright-statement><copyright-year>2012</copyright-year><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.5/"><license-p>Re-use of this article is permitted in accordance with the Creative Commons Deed,
Attribution 2.5, which does not permit commercial exploitation.</license-p></license></permissions><abstract><p>Randomization models are useful in supporting the validity of linear model
analyses applied to data from a clinical trial that employed randomization via
permuted blocks. Here, a randomization model for clinical trials data with
arbitrary randomization methodology is developed, with treatment effect
estimators and standard error estimators valid from a randomization perspective.
A central limit theorem for the treatment effect estimator is also derived. As
with permuted-blocks randomization, a typical linear model analysis provides
results similar to the randomization model results when, roughly, unit effects
display no pattern over time. A key requirement for the randomization inference
is that the unconditional probability that any patient receives active treatment
is constant across patients<bold>;</bold> when this probability condition is
violated, the treatment effect estimator is biased from a randomization
perspective. Most randomization methods for balanced, 1 to 1, treatment
allocation satisfy this condition. However, many dynamic randomization methods
for planned unbalanced treatment allocation, like 2 to 1, do not satisfy this
constant probability condition, and these methods should be avoided. Copyright
&#x000a9; 2012 John Wiley &#x00026; Sons, Ltd.</p></abstract><kwd-group><kwd>linear model</kwd><kwd>unit-treatment additivity</kwd><kwd>permuted-blocks randomization</kwd><kwd>biased-coin randomization</kwd><kwd>minimization</kwd><kwd>randomization test</kwd></kwd-group></article-meta></front><body><sec><title>1. Introduction</title><p>A theory for estimation in a linear model, specifically accounting for the
randomization used in a clinical trial will be developed. A particular goal is to
compare the inferences from the usual population-based linear model with those from
the randomization model. A further goal is to compare randomization model inference
that follows from permuted-blocks randomization (PBR) with those from dynamic
randomization methods. Here, &#x02018;dynamic randomization&#x02019; refers to
methodology in which the probability of assignment of a given patient to
experimental treatment is a function of the patient's stratification
variables and the stratification variables and treatment assignments of previously
randomized patients. Other terminology has been used, such as adaptive randomization
and minimization.</p><p>Randomization of treatments to patients in clinical trials has perhaps most commonly
been performed with PBR, often within strata defined by crossings of prognostic
factors and/or investigational sites. Permuted blocks are used instead of
&#x02018;complete randomization&#x02019;, which assigns the next patient to
experimental treatment essentially by a fair coin toss, to ensure that the number of
patients assigned to each treatment group remains similar within strata, regardless
of the number of patients ultimately enrolled in the strata [<xref ref-type="bibr" rid="b1">1</xref>]. Efron [<xref ref-type="bibr" rid="b2">2</xref>] introduced biased-coin randomization, which assigns
the next patient to experimental treatment with a biased coin if the counts of
patients previously assigned to the two treatments are imbalanced. Pocock and Simon
[<xref ref-type="bibr" rid="b3">3</xref>] generalized the method
to include stratification variables, where the probability of assignment to
experimental treatment depends on the balance of treatment counts across the margins
of the stratification variables. There have subsequently been many proposals for
other dynamic randomization procedures [<xref ref-type="bibr" rid="b4">4</xref>&#x02013;<xref ref-type="bibr" rid="b7">7</xref>].</p><p>A theory for estimation and testing exists for permutation-based randomizations
paired with a linear model, where the linear model includes the
randomization's stratification variables in addition to a treatment term, and
leads to unbiased estimators of treatment effects and unbiased estimators of the
variance of the treatment effect estimator [<xref ref-type="bibr" rid="b8">8</xref>&#x02013;<xref ref-type="bibr" rid="b11">11</xref>]. The
unbiasedness is over the distribution of the observations induced by repeated
randomizations of treatments to fixed experimental units, under the assumption of
unit-treatment additivity with fixed unit and treatment effects.</p><p>There have been many theoretical developments for randomizations that are not of the
permutation type, but these have mostly focused on randomization tests rather than
estimation.</p><list list-type="simple"><list-item><p>&#x025e6; Smythe and Wei [<xref ref-type="bibr" rid="b12">12</xref>] derived the asymptotic distribution of a linear rank test
of the null hypothesis of equality of two treatments when the assignment of
treatments to patients is according to an urn-based randomization
scheme.</p></list-item><list-item><p>&#x025e6; Smith [<xref ref-type="bibr" rid="b13">13</xref>]
summarized treatment allocation methods developed to date. For treatment
allocation probabilities that are functions of
(<italic>n</italic><sub>1</sub> &#x02212; <italic>n</italic><sub>0</sub>)
/ (<italic>n</italic><sub>0</sub> + <italic>n</italic><sub>1</sub>),
where the <italic>n</italic><sub><italic>j</italic></sub>'s are the
numbers of patients previously assigned to the two treatments, Smith
developed an approximation to a randomization test based on the difference
in sample means. Smith also developed similar approximations when treatment
assignment probabilities are a particular function of stratification
variables of the current and previous patients and developed asymptotic
approximations to randomization tests.</p></list-item><list-item><p>&#x025e6; Wei <italic>et al.</italic> [<xref ref-type="bibr" rid="b14">14</xref>] proposed a biased-coin scheme for the allocation of
<italic>k</italic> treatments in proportion &#x003be;<sub>1</sub>,
&#x02026;, &#x003be;<sub><italic>k</italic></sub>, where &#x003be;<sub>1</sub>
+ &#x02026; + &#x003be;<sub><italic>k</italic></sub> = 1,
and generalized the work of Smythe and Wei [<xref ref-type="bibr" rid="b12">12</xref>] to <italic>k</italic> &#x0003e; 2.</p></list-item><list-item><p>&#x025e6; Shao <italic>et al.</italic> [<xref ref-type="bibr" rid="b15">15</xref>] proposed a theory for clinical trials with dynamic
randomization, but the results were developed on an assumption of a model
that relates the dependent variable to the variables used in constructing
hypothesis tests.</p></list-item><list-item><p>&#x025e6; Rosenkranz [<xref ref-type="bibr" rid="b16">16</xref>]
explored the sampling properties of a difference in sample means under
various randomization schemes and noted that a <italic>t</italic>-test can
be very conservative with biased- coin randomization.</p></list-item></list><p>Regardless of the randomization method used, it is common in clinical trials data
analysis to apply a statistical test that is based on assumptions of random sampling
from a distribution. In general, these tests behave as follows for biased-coin and
urn-based randomizations [<xref ref-type="bibr" rid="b2">2</xref>, <xref ref-type="bibr" rid="b13">13</xref>, <xref ref-type="bibr" rid="b16">16</xref>&#x02013;<xref ref-type="bibr" rid="b18">18</xref>].</p><list list-type="simple"><list-item><p>&#x025e6; If there is low-frequency variation in the responses of patients
over time of entry into the trial, then a population-based test will tend to
result in a larger <italic>p</italic>-value than the corresponding
randomization test result. With this pattern of variation, patients enrolled
closer together in time tend to respond more similarly than patients
enrolled farther apart in time.</p></list-item><list-item><p>&#x025e6; If there is high-frequency variation in responses over enrollment
time, then a population-based test will tend to yield a smaller
<italic>p</italic>-value than the corresponding randomization test
result. In this case, patients enrolled closer together in time tend to
respond less similarly than patients enrolled farther apart in time. This is
generally noted to be less likely than the scenario above.</p></list-item><list-item><p>&#x025e6; Finally, when responses appear to come from a homogeneous,
time-independent model, then the two test results tend to be similar.</p></list-item></list><p>These same qualitative comparisons apply for PBR when the blocking in time is ignored
in the analysis [<xref ref-type="bibr" rid="b1">1</xref>], in which
case the variation in patient responses is quantified by the intrablock
correlation.</p><p>Motivation for the present work on estimation and testing under a randomization model
comes from a &#x02018;points to consider&#x02019; document on adjustment for baseline
covariates [<xref ref-type="bibr" rid="b19">19</xref>] that states
&#x02018;&#x02026; techniques of dynamic allocation such as minimization are sometimes
used to achieve balance across several factors simultaneously. Even if deterministic
schemes are avoided, such methods remain highly controversial. Thus, applicants are
strongly advised to avoid such methods.&#x02019; Furthermore, Halpern and Brown
[<xref ref-type="bibr" rid="b18">18</xref>] noted that dynamic
randomization schemes &#x02018;can lead to complex randomization distributions and
hence to complex analyses about which little is currently known, and which, in fact,
may present intractable difficulties.&#x02019; With a randomization-based theory for
estimation and testing applicable across all randomization methods, perhaps
regulatory authorities will be more accepting of dynamic randomization methods.</p><p>Section 2 contains the theory for randomization-based estimation in a linear model
with unit-treatment additivity. Section 3 evaluates the estimation of the variance
of the treatment effect estimator through a population-based linear model, in
comparison with the randomization-based variance estimator. Section 4 compares the
estimation results with randomization test results. Sections 5 through 7 explore
randomization-based inference when there is planned unbalanced treatment allocation,
like two experimental to one control. A key requirement, often not met with proposed
dynamic randomization methods for such unbalanced allocation, is that the
probability that a patient receives experimental treatment should be constant across
patients. The paper finishes with a discussion and conclusion.</p></sec><sec><title>2. The randomization model</title><p>Suppose <italic>n</italic> patients are in the trial, and they are assigned one of
two treatments: experimental or control. The probability that a patient receives
experimental treatment is a function of this patient's stratification
variables and the stratification variables and treatment assignments of previous
patients. No assumptions are made on this function just yet. Let
<bold>&#x003b4;</bold> be the <italic>n</italic> &#x000d7; 1 vector that indicates
assignment to experimental treatment: &#x003b4;<sub><italic>i</italic></sub> =
0 if patient <italic>i</italic> receives control and 1 if patient <italic>i</italic>
receives experimental treatment. Assume unit-treatment additivity, so that
<bold>y</bold>, the <italic>n</italic> &#x000d7; 1 vector of observations on the
patients, is</p><p>
<disp-formula id="m1"><graphic xlink:href="sim0031-3858-mu1"/></disp-formula></p><p>for unknown constant unit effects <bold>y</bold><sub>0</sub> and a scalar treatment
effect &#x003c4;. A vector of independent and identically distributed random
variables could be added as an error term to the model, but this only complicates
the development without changing the conclusions.</p><p>Let <bold>X</bold> be an <italic>n</italic> &#x000d7; <italic>q</italic> matrix of
covariates measured on the patients. Typically, some or all of the stratification
variables used in the randomization will be included in <bold>X</bold>, but this is
not required in what follows. Also, it will typically be thought that the variables
in <bold>X</bold> are prognostic of patient outcome, but there is no assumed
relationship between the unit effects in <bold>y</bold><sub>0</sub> and the
covariates in <bold>X</bold>. The only requirement is that <bold>1</bold>, an
<italic>n</italic> &#x000d7; 1 vector of ones, is in the column space of
<bold>X</bold> and, without loss of generality, <bold>X</bold> has full column
rank. As a simple example, <bold>X</bold> could have two columns, with the first
column containing 1s and the second column denoting Eastern Cooperative Oncology
Group performance status of 1 or more. An analysis of covariance example has
<bold>X</bold> with a column of 1s and a column for a continuous covariate.</p><p>We want to estimate &#x003c4; after adjustment for <bold>X</bold>, and so use the
normal equations</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu2"/></disp-formula></p><p>where <bold><italic>&#x003b2;</italic></bold> is a vector of nuisance parameters. With
simple matrix algebra,</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu3"/></disp-formula></p><p>It is worthwhile to explicitly state what is fixed and what is random in this set-up,
because this will provide the relative frequency basis for the inferences. The
patients have entered the study in a given order, and while they could conceptually
have entered in a different order, it is not clear what a reasonable probability
model should be for these other potential patient entry orders. Also, would the
patients&#x02019; unit effects be different if they entered in a different order, and
how should these effects be modeled? Would the patients&#x02019; baseline
covariates differ? Thus, patient entry order, the unknown unit effects, and
patient covariates are considered fixed. What does clearly vary, and in a way that
we can model, is the treatment assignment to patients, as captured in
<bold>&#x003b4;</bold>. The variability in the observations <bold>y</bold> then
comes only from the randomization mechanism, and the conceptual repetitions of the
study arise from independent applications of the randomization method to these
patients as entered with their fixed covariates and unit effects. This topic will be
addressed further in the discussion section.</p><p>Up to this point, no assumptions have been made on the randomization algorithm, and
the only one needed to make progress is that <italic>E</italic><bold>&#x003b4;</bold>
= <italic>p</italic><bold>1</bold>, with <italic>p</italic> a constant: 1 to1
randomization would have <italic>p</italic> = 0.5, 2 to 1 randomization would
have <italic>p</italic> = 2 / 3, and so on. The problems with randomization
methods with <italic>E</italic><bold>&#x003b4;</bold> &#x02260;
<italic>p</italic><bold>1</bold> are addressed in Section 6.</p><p>This restriction to <italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold> means that the unconditional probability that
each patient receives experimental treatment is constant, even though the
probability that a patient receives experimental treatment, conditional on the
treatment allocations of previous patients, will often be different from
<italic>p</italic> to more closely attain treatment balance, either overall or
within stratification variable groupings. Note that it is not enough that
<italic>E</italic><bold>&#x003b4;</bold> averages to the desired fraction, like
(1 /
<italic>n</italic>)<bold>1</bold><sup><bold><italic>&#x02032;</italic></bold></sup><italic>E</italic><bold>&#x003b4;</bold>
= 1 / 2. With 1 to 1 treatment allocation, the
<italic>E</italic><bold>&#x003b4;</bold> = (1 / 2)<bold>1</bold> condition
is easily satisfied because of the usual symmetry present in randomization
algorithms, while dynamic randomization algorithms for unbalanced treatment
allocations often do not maintain a constant
<italic>E</italic>&#x003b4;<sub><italic>i</italic></sub> value [<xref ref-type="bibr" rid="b20">20</xref>]. Examples of this are given in
Section 6.1 and a potential solution for certain cases is given in Section 6.</p><p>Note that <inline-formula><inline-graphic xlink:href="sim0031-3858-mu4.jpg" mimetype="image"/></inline-formula> is a function of
<bold>&#x003b4;</bold><sup><bold><italic>&#x02032;</italic></bold></sup><bold>M</bold><bold>&#x003b4;</bold>,
which does not depend on unknown parameters and so is an ancillary statistic. In
simple cases, as in <xref ref-type="table" rid="tblI">Table I</xref>,
<bold><italic>&#x003b4;&#x02032;</italic></bold><bold>M</bold><bold>&#x003b4;</bold>
is a function of sample sizes within the strata, and most would prefer to condition
on observed sample sizes [<xref ref-type="bibr" rid="b21">21</xref>].
As shown in Appendix B,
<bold>&#x003b4;</bold><sup><bold><italic>&#x02032;</italic></bold></sup><bold>M</bold><bold>&#x003b4;</bold>
/ <italic>n</italic> converges in probability to <italic>p</italic>(1 &#x02212;
<italic>p</italic>) under mild conditions, so for large samples, inference that
is conditional on
<bold><italic>&#x003b4;&#x02032;</italic></bold><bold>M</bold><bold>&#x003b4;</bold>
and unconditional inference should be similar. However, for small samples,
conditional inference may be preferred, so both approaches are developed in the next
sections.</p><table-wrap id="tblI" position="float"><label>Table I</label><caption><p><italic>&#x003b4;&#x02032;</italic>M&#x003b4; for three examples of the X
matrix</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" rowspan="1" colspan="1">X</th><th align="center" rowspan="1" colspan="1">&#x003b4;&#x02032;M&#x003b4;</th></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Intercept term only</td><td align="left" rowspan="1" colspan="1">(1 / <italic>n</italic><sub>0</sub> + 1 /
<italic>n</italic><sub>1</sub>)<sup>&#x02212;1</sup>, where
<italic>n</italic><sub><italic>j</italic></sub> is the number of
patients on treatment <italic>j</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Two columns denoting membership in one of two strata,
such as low ECOG status vs. high status</td><td align="left" rowspan="1" colspan="1">(1 / <italic>n</italic><sub>10</sub> + 1 /
<italic>n</italic><sub>11</sub>)<sup>&#x02212;1</sup> + (1
/ <italic>n</italic><sub>20</sub> + 1 /
<italic>n</italic><sub>21</sub>)<sup>&#x02212;1</sup>, where
<italic>n</italic><sub><italic>ij</italic></sub> is the number
of patients on treatment <italic>j</italic> in stratum
<italic>i</italic></td></tr><tr><td align="left" rowspan="1" colspan="1">Intercept and continuous covariate as in an ANCOVA</td><td align="left" rowspan="1" colspan="1"><inline-formula><inline-graphic xlink:href="sim0031-3858-mu5.jpg" mimetype="image"/></inline-formula>, where
<italic>n</italic><sub><italic>j</italic></sub> is the number of
patients on treatment <italic>j</italic>,
<italic>x</italic><sub><italic>ij</italic></sub> is the
covariate value of patient <italic>j</italic> on treatment
<italic>i</italic></td></tr></tbody></table></table-wrap><sec><title>2.1. Unconditional inference</title><p>Appendix A.1 develops approximations to the mean and variance of
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu6.jpg" mimetype="image"/></inline-formula> under the
restrictions of <italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold> and unit-treatment additivity and without
conditioning on a given <bold>&#x003b4;&#x02032;M&#x003b4;</bold> value. First,
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu7.jpg" mimetype="image"/></inline-formula> is an approximately
unbiased estimator of &#x003c4;. Second,</p><p><disp-formula id="m8"><graphic xlink:href="sim0031-3858-m8"/><label>(1)</label></disp-formula></p><p>where tr() denotes the trace of a matrix and <bold>V</bold> =
Var(<bold>&#x003b4;</bold>) is the variance&#x02013;covariance matrix of
<bold>&#x003b4;</bold>. <inline-formula><inline-graphic xlink:href="sim0031-3858-mu9.jpg" mimetype="image"/></inline-formula> is a function of
the residuals in the regression of <bold>y</bold><sub>0</sub> on <bold>X</bold>,
so good use of covariance adjustment reduces the variance, which is as it should
be. It is not so clear what the role of the randomization method is in the
reduction of variance, because it is tied up in the <bold>V</bold> matrix. As an
example, however, especially in a small study with a stratified analysis, a
stratified permuted-blocks randomization is better than unstratified
permuted-blocks randomization [<xref ref-type="bibr" rid="b22">22</xref>,
<xref ref-type="bibr" rid="b23">23</xref>].</p><p>Next, it is shown in Appendix A.1 that</p><p><disp-formula id="m10"><graphic xlink:href="sim0031-3858-m10"/><label>(2)</label></disp-formula></p><p>is an approximately unbiased estimator of the <inline-formula><inline-graphic xlink:href="sim0031-3858-mu11.jpg" mimetype="image"/></inline-formula> approximation of
Equation
(<xref ref-type="disp-formula" rid="m1">1</xref>). Finally, under mild
conditions it is shown in Appendix B that <inline-formula><inline-graphic xlink:href="sim0031-3858-mu12.jpg" mimetype="image"/></inline-formula> has asymptotically
a standard normal distribution, so that tests and confidence intervals on
&#x003c4; can be determined in the usual way.</p><p>In a common class of randomization methods, <inline-formula><inline-graphic xlink:href="sim0031-3858-mu13.jpg" mimetype="image"/></inline-formula> is unbiased, and
not just approximately unbiased. Define a symmetrical 1 to 1 randomization
method as one with <italic>P</italic>(<bold>&#x003b4;</bold> =
<bold><italic>&#x003b4;</italic></bold><sub>0</sub>) =
<italic>P</italic>(<bold>&#x003b4;</bold> = <bold>1</bold> &#x02212;
<bold>&#x003b4;</bold><sub>0</sub>) for each treatment assignment sequence
<bold>&#x003b4;</bold><sub>0</sub>. In words, the probability of obtaining
any treatment sequence equals the probability of that sequence with the
treatments switched between experimental and control. Most 1 to 1 randomization
methods treat the experimental and control arms symmetrically and satisfy this
condition. For such randomization methods, the unbiasedness of
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu14.jpg" mimetype="image"/></inline-formula> is shown in
Appendix A.1.</p><p>The diagonal elements of <bold>V</bold> are <italic>p</italic>(1 &#x02212;
<italic>p</italic>) and the off-diagonal elements are
<italic>E</italic>(&#x003b4;<sub><italic>i</italic></sub>&#x003b4;<sub><italic>j</italic></sub>)
&#x02212; <italic>p</italic><sup>2</sup>, where
<italic>E</italic>(&#x003b4;<sub><italic>i</italic></sub>&#x003b4;<sub><italic>j</italic></sub>)
is the probability that patients <italic>i</italic> and <italic>j</italic> both
receive experimental treatment. Analytical expressions for the first two moments
of counts of assignments to treatments for urn-based randomizations
[<xref ref-type="bibr" rid="b24">24</xref>] and for
biased-coin randomizations [<xref ref-type="bibr" rid="b25">25</xref>] are available. For some cases,
<italic>E</italic>(&#x003b4;<sub><italic>i</italic></sub>&#x003b4;<sub><italic>j</italic></sub>)
can be determined algorithmically by stepping through all assignment
probabilities [<xref ref-type="bibr" rid="b26">26</xref>].
Alternatively, a straightforward solution for any randomization method is to
rerandomize treatments to the patients in the trial according to the
trial's algorithm millions of times and estimate <bold>V</bold> with the
sample variance&#x02013;covariance matrix of the resulting
<bold>&#x003b4;</bold>s.</p></sec><sec><title>2.2. Conditional inference</title><p>For symmetrical 1 to 1 randomizations as defined above, inference conditional on
a <bold>&#x003b4;&#x02032;M&#x003b4;</bold> value is developed in Appendix B.1,
where first it is shown that <inline-formula><inline-graphic xlink:href="sim0031-3858-mu15.jpg" mimetype="image"/></inline-formula>. Furthermore,
letting <inline-formula><inline-graphic xlink:href="sim0031-3858-mu16.jpg" mimetype="image"/></inline-formula>, it is shown
that</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu17"/></disp-formula></p><p>where <inline-formula><inline-graphic xlink:href="sim0031-3858-mu18.jpg" mimetype="image"/></inline-formula>. Finally,</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu19"/></disp-formula></p><p>is a conditionally unbiased estimator of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu20.jpg" mimetype="image"/></inline-formula>.</p><p>Because most 1 to 1 randomizations are symmetrical, conditional inference is
straightforward, as outlined above. For planned unbalanced allocation, however,
even when <italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold>,
<italic>E</italic>(&#x003b4;<sub><italic>i</italic></sub> |
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> = <italic>c</italic>) is
typically not constant over <italic>i</italic>. For example, consider PBR in
blocks of 6 in a 2 to 1 ratio to 10 patients, with <bold>M</bold> =
<bold>I</bold> &#x02212; <bold>J</bold> / 12. Unconditionally,
<italic>E</italic>&#x003b4;<sub><italic>i</italic></sub> = 2 / 3.
However, from <xref ref-type="table" rid="tblI">Table I</xref>, if
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> = (1 / 8 + 1 /
2)<sup>&#x02212;1</sup> = 1.6, then
<italic>E</italic>(&#x003b4;<sub><italic>i</italic></sub> |
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> = 1.6) = 2 / 3 for 1
<italic>&#x02264; i &#x02264;</italic>6, but
E(&#x003b4;<sub><italic>i</italic></sub> |
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> = 1.6) = 1 for 7
<italic>&#x02264; i &#x02264;</italic>10.</p><p>The variation in the conditional probability of assignment to experimental
treatment leads to conditional bias in <inline-formula><inline-graphic xlink:href="sim0031-3858-mu21.jpg" mimetype="image"/></inline-formula>. Let
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu22.jpg" mimetype="image"/></inline-formula>, then</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu23"/></disp-formula></p><p>and the conditional bias is proportional to the covariance between
<bold>p</bold><sub>c</sub> and <bold>M</bold><bold>y</bold><sub>0</sub>. The
problem of conditional inference for planned unbalanced allocations with
<italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold> is illustrated in Section 5 and a potential
solution is raised in the conclusion section.</p></sec></sec><sec><title>3. Comparison of standard error estimators &#x02014; linear model versus
randomization model</title><p>Regardless of the randomization method used, it is common to analyze trial data with
a population-based linear model</p><p><disp-formula id="m24"><graphic xlink:href="sim0031-3858-m24"/><label>(3)</label></disp-formula></p><p>The elements of <bold><italic>&#x003f5;</italic></bold> are independent and
identically distributed with zero mean and variance &#x003c3;<sup>2</sup>,
<bold>&#x003b4;</bold> is considered fixed, and <bold>X</bold> often includes
stratification factors that are balanced by the randomization [<xref ref-type="bibr" rid="b27">27</xref>]. It is common, however, to ignore in
the model the balancing in time that randomizations typically achieve.</p><p>By construction, the treatment effect estimator is the same under the randomization
model as under model (<xref ref-type="disp-formula" rid="m24">3</xref>); however,
the variance estimator from Equation (<xref ref-type="disp-formula" rid="m10">2</xref>) will generally differ from the variance estimator derived from model
(<xref ref-type="disp-formula" rid="m24">3</xref>). How similar are these
estimators from a randomization perspective? The estimators will undoubtedly
be different in any particular trial, but it is informative to consider their
expectations.</p><p>The linear model estimate of the variance of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu25.jpg" mimetype="image"/></inline-formula> is</p><p><disp-formula id="m26"><graphic xlink:href="sim0031-3858-m26"/><label>(4)</label></disp-formula></p><p>What is the expectation of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu27.jpg" mimetype="image"/></inline-formula> from a randomization
perspective? Again, the numerator and denominator both contain random
variables, but approximate by simply taking expectations individually of the
numerator and denominator to obtain</p><p><disp-formula id="m28"><graphic xlink:href="sim0031-3858-m28"/><label>(5)</label></disp-formula></p><p>where the subscript r on <italic>E</italic><sub>r</sub> and Var<sub>r</sub> denotes
expectation and variance over the randomization method used. For what unit effects
<bold>y</bold><sub>0</sub> might <inline-formula><inline-graphic xlink:href="sim0031-3858-mu29.jpg" mimetype="image"/></inline-formula> be similar to, less
than, or greater than <inline-formula><inline-graphic xlink:href="sim0031-3858-mu30.jpg" mimetype="image"/></inline-formula>? Some guidance
is given in the next two sections.</p><sec><title>3.1. Linear model versus randomization model standard error estimators when
no pattern is expected for unit effects</title><p>Suppose that apart from dependence on <bold>X</bold>, the unit effects
<bold>y</bold><sub>0</sub> display no further systematic variation. A
reasonable model for this is <bold>y</bold><sub>0</sub> =
<bold>X</bold><bold>&#x003b2;</bold> + <bold>e</bold>, where
<bold>e</bold> is a vector of independent and identically distributed random
variables with expectation zero and finite variance &#x003c3;<sup>2</sup>. It is
easy to see that the expectation of both <inline-formula><inline-graphic xlink:href="sim0031-3858-mu31.jpg" mimetype="image"/></inline-formula> and
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu32.jpg" mimetype="image"/></inline-formula> equals
&#x003c3;<sup>2</sup> / tr<bold>M</bold><bold>V</bold>.</p><p>Therefore, if no discernable pattern in unit effects is expected, apart from
variation owing to dependence on <bold>X</bold>, then the usual linear model
estimate of the estimated treatment effect variance estimates a quantity similar
to the proper randomization variance. This is true regardless of the type of
randomization, as long as <italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold>.</p><p>Note also that if complete randomization were used, with <bold>V</bold> =
<italic>p</italic>(1 &#x02212; <italic>p</italic>)<bold>I</bold>, then the
randomization model variance estimator in (<xref ref-type="disp-formula" rid="m10">2</xref>) equals the linear model estimator in (<xref ref-type="disp-formula" rid="m26">4</xref>), illustrating the equivalence of
randomization-based and population-based inference with complete randomization
[<xref ref-type="bibr" rid="b28">28</xref>].</p></sec><sec><title>3.2. Linear model versus randomization model standard error estimators when
unit effects have systematic variation</title><p>The difference between the expectation of the linear model variance estimator in
Equation (<xref ref-type="disp-formula" rid="m28">5</xref>) and the
randomization variance in Equation (<xref ref-type="disp-formula" rid="m1">1</xref>) is proportional to <inline-formula><inline-graphic xlink:href="sim0031-3858-mu33.jpg" mimetype="image"/></inline-formula>. These quadratic
forms have been evaluated in the context of accidental bias by Efron
[<xref ref-type="bibr" rid="b2">2</xref>] and Smith
[<xref ref-type="bibr" rid="b13">13</xref>] for biased-coin
randomization.</p><p>Efron defined accidental bias as the expectation, over the randomization used, of
the squared bias of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu34.jpg" mimetype="image"/></inline-formula> calculated under
an assumed regression model for the observations, where the regression model
includes a covariate <bold>z</bold> not accounted for in the treatment effect
estimator. This squared bias is proportional to <bold>z&#x02032;MVMz</bold>, and
therefore the work of these authors applies to the comparison of variance
estimators considered here. The applicable conclusion for biased-coin
randomization is that when unit effect residuals, after regression on
<bold>X</bold>, exhibit low-frequency variation or a smooth trend from
patient to patient, then the linear model estimate of variance will tend to be
larger than the randomization model estimate. With high-frequency variation, the
comparison of the variances is reversed.</p><p>Urn randomization is asymptotically free of accidental bias [<xref ref-type="bibr" rid="b17">17</xref>] so that for very large samples,
the linear model variance estimate is likely to be similar to the
randomization-based variance. For smaller samples, the control of sample size
differences achieved by urn randomization is likely to lead to comparisons of
variances similar to those for biased-coin randomization.</p><p>This parallels the situation with PBR where the variance estimate ignoring the
blocking in time will generally be greater than the estimate accounting for this
blocking when there is low-frequency variation or a smooth time trend in the
unit effect residuals, as quantified by the intrablock correlation [<xref ref-type="bibr" rid="b1">1</xref>].</p></sec></sec><sec><title>4. Randomization tests</title><p>The null hypothesis that treatment has absolutely no effect in any patient can be
tested with a randomization test. Under this hypothesis, the vector of observations
<bold>y</bold> equals <bold>y</bold><sub>0</sub>, and the observed
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu35.jpg" mimetype="image"/></inline-formula> is just one of the
possible treatment effect estimates that could be obtained by the random assignment
of treatment labels to these patients. Is the observed
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu36.jpg" mimetype="image"/></inline-formula> unusually large or
small in this distribution of possible <inline-formula><inline-graphic xlink:href="sim0031-3858-mu37.jpg" mimetype="image"/></inline-formula> values?</p><p>A randomization test is implemented by performing the randomization repeatedly with
the patients enrolled in their fixed order and determining the resulting
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu38.jpg" mimetype="image"/></inline-formula> values. For an
alternative hypothesis of positive &#x003c4;, the randomization test
<italic>p</italic>-value is estimated as the fraction of the
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu39.jpg" mimetype="image"/></inline-formula> values that are
greater than the observed <inline-formula><inline-graphic xlink:href="sim0031-3858-mu40.jpg" mimetype="image"/></inline-formula>; for a two-sided
alternative, compare <inline-formula><inline-graphic xlink:href="sim0031-3858-mu41.jpg" mimetype="image"/></inline-formula> to
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu42.jpg" mimetype="image"/></inline-formula>. As with estimation,
the randomization test can be performed conditionally on
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> = <italic>c</italic> or
unconditionally. For the conditional randomization test, only those randomizations
with <bold>&#x003b4;&#x02032;M&#x003b4;</bold> = <italic>c</italic>, or suitably
close to it, are used for the generation of the <inline-formula><inline-graphic xlink:href="sim0031-3858-mu43.jpg" mimetype="image"/></inline-formula> values.</p><p>What are the first two moments of this randomization distribution of
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu44.jpg" mimetype="image"/></inline-formula>? With
<italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold>, from Section 2.1, unconditionally
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu45.jpg" mimetype="image"/></inline-formula> and</p><p><disp-formula id="m46"><graphic xlink:href="sim0031-3858-m46"/><label>(6)</label></disp-formula></p><p>Under the asymptotic normality conditions at the beginning of Appendix B, an
approximation to the randomization test would be to compare
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu47.jpg" mimetype="image"/></inline-formula> with standard normal
quantiles. This test statistic is similar to the <italic>Z</italic>-statistic
obtained from use of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu48.jpg" mimetype="image"/></inline-formula> from Equation (<xref ref-type="disp-formula" rid="m10">2</xref>), except that a &#x02018;sum of
squares for treatment&#x02019; is removed in (2) relative to the variance in the
randomization distribution. Through use of approximations as in Appendix A.1, the
expectation of Equation (<xref ref-type="disp-formula" rid="m46">6</xref>) exceeds
that of Equation (<xref ref-type="disp-formula" rid="m10">2</xref>) by approximately
&#x003c4;<sup>2</sup>tr<bold>M</bold><bold>V</bold><bold>M</bold><bold>V</bold> /
(tr<bold>M</bold><bold>V</bold>)<sup>2</sup>, which is small for small &#x003c4;
or large <italic>n</italic>.</p><p>Thus, the randomization test inference will necessarily be similar to the inference
that comes from simple use of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu49.jpg" mimetype="image"/></inline-formula> and its estimated
standard error. As above, however, if the estimated standard error is obtained from
a linear model based on <bold>X</bold>, then the randomization test need not agree
with the linear model results. From Section 3.1, when the unit effects display no
trend apart from dependence on <bold>X</bold> then the randomization inference
should be similar to that from linear model inference. Likewise, from Section 3.2,
when unit effects display a low-frequency trend, then the randomization test
<italic>p</italic>-value would be expected to be smaller than the
<italic>p</italic>-value from the linear model, with the reverse order when the
unit effects display high-frequency variation. This agrees with the summary of
randomization tests given in the introduction.</p></sec><sec><title>5. Conditional inference with planned unbalanced treatment allocation
ratio</title><p>Section 2.2 noted that planned unbalanced treatment allocation with
<italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold> yields an approximately unbiased treatment
effect estimator unconditionally, but the estimator is typically biased conditioned
on a <bold>&#x003b4;&#x02032;M&#x003b4;</bold> value. This section illustrates by
example the potential for bias with conditional inference and shows that the problem
is applicable to PBR and to dynamic randomization.</p><p>Consider the randomization of two treatments to 38 patients in a 2 to 1 ratio, with
patients categorized by two binary stratification variables. The patient counts in
the four cells defined by these two variables are respectively 10, 8, 11, and 9 for
cells (0,0), (0,1), (1,0), and (1,1), with the first value of the pair indicating
the Stratum 1 level and the second value indicating the Stratum 2 level. The order
of entry of these patients to the simulated trial was determined at random and then
held fixed.</p><p>Two randomization methods are evaluated. The first is stratified PBR, with 2 to 1
allocation in blocks of six applied independently within each of the four cells. The
second is a sequential method that follows the recommendation at the end of Section
6.1 to perform a symmetrical 1 to 1 to 1 randomization with three treatments, with
two treatment arms subsequently combined (see Appendix C for details). The matrix
<bold>X</bold> includes an intercept and main effects for the two strata. Each
randomization method was replicated 10 million times to determine the
<bold>V</bold><sub>c</sub> matrices for this population. The methods were
subsequently replicated one million times to determine the conditional properties of
the estimators.</p><p>For each randomization method, the expected value of the ancillary statistic
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> is 8.3 and approximately 90% of
the <bold>&#x003b4;&#x02032;M&#x003b4;</bold> values are between 7.7 and 8.9; smaller
values represent randomizations that generally exceed the 2 to 1 ratio and larger
values represent randomizations with closer to 1 to 1 allocation. <xref ref-type="fig" rid="fig01">Figure 1</xref> illustrates the fluctuation across
the patients in the empirically estimated
<italic>E</italic>(&#x003b4;<sub><italic>i</italic></sub> |
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> = <italic>c</italic>) for selected
values of <italic>c</italic>, grouped to the nearest 0.2. For stratified PBR,
<italic>E</italic>(&#x003b4;<sub><italic>i</italic></sub> |
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> = <italic>c</italic>) is exactly
2/3 for earlier patients who belong to complete blocks, and similarly for the
sequential method, <italic>E</italic>(&#x003b4;<sub><italic>i</italic></sub> |
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> = <italic>c</italic>) is
approximately 2/3 for early patients. However, for patients in incomplete blocks
with PBR and for the later patients with the sequential method, the conditional
probability of assignment to active treatment diverges from 2/3, with
<italic>E</italic>(&#x003b4;<sub><italic>i</italic></sub> |
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> = <italic>c</italic>) generally
above 2/3 for smaller values of <italic>c</italic> and below 2/3 for larger values
of <italic>c</italic>.</p><fig id="fig01" position="float"><label>Figure 1</label><caption><p>E(&#x003b4;i | &#x003b4;&#x02032;M&#x003b4; = c) versus patient
randomization order, with values of c grouped to the nearest 0.2. (a)
Stratified permuted-blocks randomization and (b) sequential randomization.
See text for details on these randomization methods.</p></caption><graphic xlink:href="sim0031-3858-f1"/></fig><p>From Section 2.2, the conditional bias is proportional to the covariance between
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu50.jpg" mimetype="image"/></inline-formula> and the residuals of
the unit effects after regression on <bold>X</bold>. Suppose here that unit effects
are related to order of patient entry via a simple linear regression with a positive
slope and coefficient of determination <italic>R</italic><sup>2</sup>, and let
<italic>E</italic><sub>lm</sub> denote the expectation with respect to this
model. Through simple algebra, the expectation of the conditional bias normalized by
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu51.jpg" mimetype="image"/></inline-formula> is</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu52"/></disp-formula></p><p>where <bold>z</bold> is a unit-length vector proportional to patient randomization
order. This normalized bias is displayed in <xref ref-type="fig" rid="fig02">Figure
2</xref> for each randomization method for <italic>R</italic><sup>2</sup>
= 0.5 and <bold>X</bold> = <bold>1</bold>. The normalized bias is
similar between randomization methods and is positive for smaller values of
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> and negative for larger values of
<bold>&#x003b4;&#x02032;M&#x003b4;</bold>. At the smallest and largest values of
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> displayed the normalized bias is
approximately 10% in absolute value.</p><fig id="fig02" position="float"><label>Figure 2</label><caption><p>Conditional relative bias of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu53.jpg" mimetype="image"/></inline-formula> versus values
of &#x003b4;&#x02032;M&#x003b4; = c grouped to the nearest 0.2.
Conditional relative bias is the conditional bias of
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu54.jpg" mimetype="image"/></inline-formula> divided by the
square root of the conditional variance of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu55.jpg" mimetype="image"/></inline-formula>. See text for
details on the stratified permuted-blocks randomization and sequential
randomization methods.</p></caption><graphic xlink:href="sim0031-3858-f2"/></fig><p>Thus, for planned unbalanced treatment allocation with
<italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold>, randomization inference conditional on
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> can be problematic, and this problem is
present with both dynamic randomization and PBR. Because this problem arises in
stratified PBR only for the patients in the last potentially incomplete block in
each stratum, the bias is likely negligible in large trials. Likewise, for dynamic
randomization, although based on limited empirical evaluations,
<bold>p</bold><sub>c</sub> appears to diverge from the desired fraction only for
the latest patients randomized in a trial, so that the conditional bias for large
trials would also seem to be negligible.</p><p>The next sections shift to the problem of unconditional bias when
<italic>E</italic><bold>&#x003b4;</bold> &#x02260;
<italic>p</italic><bold>1</bold> and illustrate that this problem is common with
planned unbalanced treatment allocation.</p></sec><sec><title>6. Estimation and randomization tests when <italic>E</italic>&#x003b4; &#x02260;
<italic>p</italic>1</title><p>When <italic>E</italic><bold>&#x003b4;</bold> = <bold>p</bold> &#x02260;
<italic>p</italic><bold>1</bold>, then <inline-formula><inline-graphic xlink:href="sim0031-3858-mu56.jpg" mimetype="image"/></inline-formula> is biased. Using a
first-order approximation, the bias is</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu57"/></disp-formula></p><p>The bias is a function of the correlation between <bold>p</bold> and the residuals
from the regression of <bold>y</bold><sub>0</sub> on <bold>X</bold>.</p><p>For the randomization test when <italic>E</italic><bold>&#x003b4;</bold> &#x02260;
<italic>p</italic><bold>1</bold>, the randomization distribution of the usual
estimator <inline-formula><inline-graphic xlink:href="sim0031-3858-mu58.jpg" mimetype="image"/></inline-formula> is not centered at
zero, but at <inline-formula><inline-graphic xlink:href="sim0031-3858-mu59.jpg" mimetype="image"/></inline-formula>, approximately. This
nonzero expectation does not affect the Type I error rate by construction of the
randomization test, although the power of the test may be affected [<xref ref-type="bibr" rid="b30">30</xref>].</p><p>A notable example of <italic>E</italic><bold>&#x003b4;</bold> &#x02260;
<italic>p</italic><bold>1</bold> is contained in the documents of the
Endocrinologic and Metabolic Drugs Advisory Committee meeting held October 21, 2008
[<xref ref-type="bibr" rid="b30">30</xref>, <xref ref-type="bibr" rid="b31">31</xref>]. In this case, the linear model inference indicated
a statistically significant treatment effect, while the randomization test did not,
resulting in <italic>p</italic> = 0.035 versus <italic>p</italic> =
0.06 for the analysis of one endpoint and <italic>p</italic> = 0.046 versus
<italic>p</italic> = 0.15 for another endpoint.</p><p>Because the bias is a function of <bold>p&#x02032;My</bold><sub>0</sub>, a simple
method to obtain an approximately unbiased estimator of &#x003c4; is to augment
<bold>X</bold> with the vector <bold>p</bold>, use
[<bold>X</bold><bold>p</bold>] in the normal equations, and
proceed as before with estimation of &#x003c4; and the standard error. A
randomization test would also proceed as before. The asymptotic normality results of
Appendix B were developed with <italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold>, so it is uncertain whether asymptotic
normality applies in this case. Even if it did, the best solution is not to use
randomization methods with <italic>E</italic><bold>&#x003b4;</bold> &#x02260;
<italic>p</italic><bold>1</bold> in the first place.</p><sec><title>6.1. Dynamic randomization with planned unbalanced treatment allocation
ratio</title><p>Consider randomizations for a trial with 2 to 1 randomization of experimental to
control treatment. <italic>P</italic>(&#x003b4;<sub><italic>i</italic></sub>
= 1) = 2 / 3 for PBR applied in blocks of multiples of three. What
about biased-coin randomization? A natural attempt is to use a biased
coin whenever <italic>n</italic><sub>e</sub> / 2 differs too much from
<italic>n</italic><sub>c</sub>, where <italic>n</italic><sub>e</sub> and
<italic>n</italic><sub>c</sub> denote the number of patients previously
assigned to experimental and control. Suppose a threshold of 1 or more is used,
with <italic>P</italic>(&#x003b4;<sub><italic>i</italic></sub> = 1)
= 0.9 for too many previous control arm assignments,
<italic>P</italic>(&#x003b4;<sub><italic>i</italic></sub> = 1)
= 0.2 for too many previous experimental arm assignments, and
<italic>P</italic>(&#x003b4;<sub><italic>i</italic></sub> = 1)
= 2 / 3 otherwise. This procedure satisfies conditions C1 and C2 in
[<xref ref-type="bibr" rid="b13">13</xref>] and the
probabilities satisfy the recent recommendation of Han <italic>et al.</italic>
[<xref ref-type="bibr" rid="b6">6</xref>]. With the first
patient's assignment to experimental treatment determined with
probability 2/3, it is easy to calculate the
<italic>P</italic>(&#x003b4;<sub><italic>i</italic></sub> = 1)
values for <italic>i</italic> = 2, 3, 4, and 5 as 0.744, 0.467, 0.674,
and 0.761. Stepping through the probabilities algorithmically yields
<italic>P</italic>(&#x003b4;<sub>20</sub> = 1) = 0.775. The
probabilities do not converge to 0.667, although the average of these 20
assignment probabilities is close to 0.667.</p><p>The situation is worse with the marginal balance metric [<xref ref-type="bibr" rid="b6">6</xref>]. In this simple case, the biased
coin is applied to the treatment that yields the smaller value of
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu60.jpg" mimetype="image"/></inline-formula> versus
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu61.jpg" mimetype="image"/></inline-formula>. If the former is
smaller, then experimental treatment is assigned with probability 0.9, and if
the latter is smaller, then experimental treatment is assigned with probability
0.2. With equal values and also for the first patient, experimental treatment is
assigned with probability 2/3.
<italic>P</italic>(&#x003b4;<sub><italic>i</italic></sub> = 1)
values for <italic>i</italic> = 2, 3, 4, and 5 are 0.433, 0.807, 0.881,
and 0.342. Stepping through the probabilities algorithmically yields
<italic>P</italic>(&#x003b4;<sub>20</sub> = 1) = 0.340.</p><p>The generalization of 1 to 1 urn randomization to unbalanced allocation in
Rosenberger and Lachin [<xref ref-type="bibr" rid="b32">32</xref>]
is incorrect. For example, with 2 to 1 allocation, and starting with 2 E balls
and 1 C ball, one application of their generalization would add 2 E balls if
control treatment is assigned, with 1 C ball added if experimental treatment is
assigned. The first patient is assigned experimental treatment with probability
2/3, and <italic>P</italic>(&#x003b4;<sub><italic>i</italic></sub> = 1)
values for <italic>i</italic> = 2, 3, 4, and 5 are 0.6, 0.590, 0.589, and
0.588. These probabilities converge to 0.586. A fix in this simple case is to
add 4 E balls, rather than 2 E balls, if control treatment is assigned, with
other aspects of the method unchanged. Then the
<italic>P</italic>(&#x003b4;<sub><italic>i</italic></sub> = 1)
values for <italic>i</italic> = 2, 3, 4, and 5 are 0.620, 0.641, 0.656,
and 0.662 and the probabilities converge to 2/3. In large samples, urn sampling
behaves like complete randomization [<xref ref-type="bibr" rid="b17">17</xref>] so that deviation from the target allocation ratio is
likely to be greater with urn sampling than with other methods.</p><p>A solution for <italic>r</italic><sub>1</sub> : <italic>r</italic><sub>2</sub>
treatment allocation is to perform randomization for balanced allocation to
<italic>r</italic><sub>1</sub> + <italic>r</italic><sub>2</sub>
treatment arms, and then combine <italic>r</italic><sub>1</sub> of these arms
for the experimental arm assignment and <italic>r</italic><sub>2</sub> of these
arms for control. As long as the randomization method treats the
<italic>r</italic><sub>1</sub> + <italic>r</italic><sub>2</sub> arms
symmetrically then <italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold> will hold, and unconditional inference can
be carried out as developed above.</p></sec></sec><sec><title>7. Discussion</title><p>The estimation of &#x003c4; involves only <bold>&#x003b4;</bold>, <bold>M</bold>, and
<bold>y</bold>, and the estimator <inline-formula><inline-graphic xlink:href="sim0031-3858-mu62.jpg" mimetype="image"/></inline-formula> is approximately
unbiased as long as <italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold> and unit-treatment additivity holds. This
approximate unbiasedness is true regardless of the relationship between
<bold>y</bold><sub>0</sub> and <bold>X</bold> and any other properties of the
randomization algorithm. Therefore, at least from the point of view of unbiased
estimation of &#x003c4;, there is no natural determination of <bold>X</bold> based on
the randomization used, such as if the randomization is stratified on a particular
factor, then that factor should be included in <bold>X</bold>. However, from the
point of view of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu63.jpg" mimetype="image"/></inline-formula>, covariates that are
related to the unit effects should be included in <bold>X</bold>, as smaller
residuals from a regression of <bold>y</bold><sub>0</sub> on <bold>X</bold> reduce
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu64.jpg" mimetype="image"/></inline-formula>. It is unclear how
manipulation of the randomization scheme influences <inline-formula><inline-graphic xlink:href="sim0031-3858-mu65.jpg" mimetype="image"/></inline-formula>, but it is likely that
randomization methods that seek to balance the covariates in <bold>X</bold> between
treatment groups are somewhat better than those that do not, at least for small
studies. Finally, for a proper randomization-based variance estimator, both
<bold>X</bold> and the randomization method, through <bold>V</bold>, should be
accounted for. On this point, the advice to &#x02018;analyze as you randomize&#x02019;
should be followed.</p><p>Variability in the observations in the randomization model arises only from the
random assignment of treatments to the patients in the order they entered the trial.
This order and the patients&#x02019; baseline covariates determine the distribution
of the treatment assignment vector <bold>&#x003b4;</bold> and subsequent properties
of the treatment effect estimator. In the discussion of randomization tests, this
fixing of patient order is common [<xref ref-type="bibr" rid="b12">12</xref>,
<xref ref-type="bibr" rid="b13">13</xref>, <xref ref-type="bibr" rid="b17">17</xref>, <xref ref-type="bibr" rid="b26">26</xref>, <xref ref-type="bibr" rid="b33">33</xref>]. A reviewer asked whether study conclusions can only
be applied to these patients with the same order of entry? Now, it is common
[<xref ref-type="bibr" rid="b34">34</xref>, <xref ref-type="bibr" rid="b35">35</xref>] to consider that statistical inference in a
randomized trial applies to the actual patients in the trial, with inference to the
broader population of similar patients being either nonstatistical or based on
assumptions that trial data follow specified distributions. In answer to the
reviewer's question, it seems necessary to go a bit further and to say that
the statistical inference from the randomization model applies only to these
patients as they entered, at their specific stage of disease, and as treated at
their specific study site. It is certainly plausible that treatment would have
exerted a similar effect if patients had enrolled in a different order and under
somewhat different circumstances, but to make statistical statements about such a
treatment effect would require further assumptions.</p><p>One generalization of the model of Section 2 is to drop the assumption of
unit-treatment additivity. Let &#x003c4;<sub><italic>i</italic></sub> be the
difference in response if patient <italic>i</italic> were given experimental
treatment versus the patient's response with control treatment. The estimator
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu66.jpg" mimetype="image"/></inline-formula> in Section 2 is in
general a biased estimator of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu67.jpg" mimetype="image"/></inline-formula>, defined as the
average of the &#x003c4;<sub><italic>i</italic></sub> values across the
<italic>n</italic> patients. Using the first-order approximation to the
expectation of a ratio of random variables as in Section 2.1, the bias is a function
of a contrast in the diagonal elements of the matrix <bold>V</bold><bold>M</bold>.
These diagonal elements will often be nearly constant, in which case the bias will
be small. Gadbury [<xref ref-type="bibr" rid="b36">36</xref>] showed
for permutation-based randomizations that the usual estimator of
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu68.jpg" mimetype="image"/></inline-formula> is positively biased.
If a similar result applied to the variance estimator in Equation (<xref ref-type="disp-formula" rid="m10">2</xref>) for the more general randomizations
considered here, then the randomization model estimators would yield, for example,
nearly unbiased estimates of the average treatment effect, along with a conservative
standard error estimate and conservative hypothesis tests on
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu69.jpg" mimetype="image"/></inline-formula>.</p><p>Another generalization is to more than two treatments. This appears to be relatively
straightforward for a continuous endpoint with unit-treatment additivity through the
introduction of a separate <bold>&#x003b4;</bold> vector for each of
<italic>t</italic> &#x02212; 1 treatments.</p><p>It would be interesting to see whether randomization model inference could be
extended from the continuous endpoints considered here to binary responses and
time-to-event endpoints. Certainly, randomization tests of a null hypothesis of no
treatment effect in any patient are available for such endpoints, but treatment
effect estimation from a randomization perspective does not seem to be
available.</p><p>In addition to the analysis of the whole trial, it is important to explore treatment
effects within subgroups of patients. If <italic>E</italic><bold>&#x003b4;</bold>
= <italic>p</italic><bold>1</bold> and there is unit-treatment additivity
within the subgroup, then a linear model estimate within the subgroup of this common
treatment effect as in Section 2 is approximately unbiased, regardless of the
covariates included in such an estimate. An estimate of the standard error of this
estimator could come from Equation (<xref ref-type="disp-formula" rid="m10">2</xref>), with <bold>V</bold> determined only from this subset of patients. As in
Section 3.1, if unit effects within this subset are expected to display no
systematic variation other than dependence on the covariates, then the linear model
estimate of the standard error should be a reasonable approximation to the
randomization-based standard error estimate.</p></sec><sec><title>8. Conclusion</title><p>For symmetrical 1 to 1 randomization, inference conditional on
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> and unconditional inference are both
straightforward, and a randomization test will necessarily be similar to a test
result obtained from <inline-formula><inline-graphic xlink:href="sim0031-3858-mu70.jpg" mimetype="image"/></inline-formula> and its estimated
variance, which is justified by a central limit theorem. With planned unbalanced
treatment allocation, Proschan <italic>et al.</italic> [<xref ref-type="bibr" rid="b30">30</xref>] argued to &#x02018;minimize the use of
minimization.&#x02019; However, it is only with
<italic>E</italic><bold>&#x003b4;</bold> &#x02260;
<italic>p</italic><bold>1</bold> that unconditional inference is problematic.
Unfortunately, as illustrated in Section 6.1, many dynamic randomization methods for
planned unbalanced allocation result in <italic>E</italic><bold>&#x003b4;</bold>
&#x02260; <italic>p</italic><bold>1</bold>, and care must be exercised to achieve
<italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold>, in which case unconditional inference is also
straightforward. Although likely only relevant for smaller trials, with
<italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold> and planned unbalanced allocation, conditional
inference will typically lead to bias in <inline-formula><inline-graphic xlink:href="sim0031-3858-mu71.jpg" mimetype="image"/></inline-formula>. This conditional bias
is also present with PBR when the blocking in time is ignored in the analysis. A
potential repair to <inline-formula><inline-graphic xlink:href="sim0031-3858-mu72.jpg" mimetype="image"/></inline-formula> is to include, as
suggested in Section 6 for unconditional inference, <inline-formula><inline-graphic xlink:href="sim0031-3858-mu73.jpg" mimetype="image"/></inline-formula> as a covariate in
<bold>X</bold> and proceed with inference based on
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu74.jpg" mimetype="image"/></inline-formula>. This possible repair
needs further evaluation.</p><p>An additional similarity between PBR and dynamic randomization methods that attempt
to balance treatment counts is that inference from a population-based model will
likely be similar to a randomization-based analysis when unit effects, or rather the
residuals from the regression of unit effects on <bold>X</bold>, are essentially
sampled from a homogenous population. Furthermore, for both PBR and dynamic methods,
when unit effect residuals display low-frequency variation or a general trend
related to enrollment time, then the estimated variance of
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu75.jpg" mimetype="image"/></inline-formula> from a
population-based model will tend to overestimate the randomization-based variance,
with the opposite order in variance terms for high-frequency variation.</p><p>In our company's experience, the use of dynamic randomization has never been
an issue in disqualifying a positive study. However, at the time of protocol review,
we often receive comments from health authority review staff on our randomization
method and trial analysis methods. It is very common that we receive a request for a
randomization test for the main trial endpoints. I believe we would not receive such
comments and requests if we routinely used PBR. With the results of this manuscript,
owing to the similarity between randomization inference for dynamic randomization
and PBR, it seems inconsistent to single out dynamic methods for the performance of
a randomization test. Given that the blocking in time achieved by PBR and dynamic
methods is routinely ignored in analyses, one should either (1) be satisfied that
these analyses are likely to match a randomization analysis or to be conservative or
(2) ask for a randomization test for any randomization method other than complete
randomization.</p></sec></body><back><ack><p>I thank the reviewers for their helpful comments that led to substantial improvements
in this manuscript.</p></ack><app-group><app id="app1"><title>Appendix A.1</title><p>Approximations to the unconditional moments of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu76.jpg" mimetype="image"/></inline-formula> will be developed
here under the assumptions of <italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold> and unit-treatment additivity. Recall that
<bold>X</bold> is an <italic>n</italic> &#x000d7; <italic>q</italic> full
column rank matrix with <bold>1</bold> in its column space and that
<bold>M</bold> = <bold>I</bold> &#x02212;
<bold>X</bold>(<bold>X&#x02032;X</bold>)<sup>&#x02212;1</sup><bold>X</bold>.
First, note that</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu77"/></disp-formula></p><p>so that the moments of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu78.jpg" mimetype="image"/></inline-formula> can be found from
the moments of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu79.jpg" mimetype="image"/></inline-formula>. Approximate this
ratio with a first-degree Taylor series expansion about the means of the
numerator and denominator to obtain the approximation
<bold>&#x003b4;&#x02032;My</bold><sub>0</sub> /
tr<bold>M</bold><bold>V</bold>, where <bold>V</bold> =
Var(<bold>&#x003b4;</bold>) and tr() denotes the trace of a matrix. Thus,</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu80"/></disp-formula></p><p>because <bold>1</bold> is in the column space of <bold>X</bold>, so that
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu81.jpg" mimetype="image"/></inline-formula>. Therefore,
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu82.jpg" mimetype="image"/></inline-formula> is approximately
unbiased.</p><p>For the variance of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu83.jpg" mimetype="image"/></inline-formula>,</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu84"/></disp-formula></p><p>For the estimation of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu85.jpg" mimetype="image"/></inline-formula>, note that</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu86"/></disp-formula></p><p>Define</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu87"/></disp-formula></p><p>It is easy to see that</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu88"/></disp-formula></p><p>Because <inline-formula><inline-graphic xlink:href="sim0031-3858-mu89.jpg" mimetype="image"/></inline-formula>,
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu90.jpg" mimetype="image"/></inline-formula> is an
approximately unbiased estimator of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu91.jpg" mimetype="image"/></inline-formula>.</p><p>A problem with <inline-formula><inline-graphic xlink:href="sim0031-3858-mu92.jpg" mimetype="image"/></inline-formula>, inherent in its
unconditional nature, is that it averages over variation in
<bold>&#x003b4;&#x02032;M&#x003b4;</bold>. A potentially better estimator that
explicitly depends on <bold>&#x003b4;&#x02032;M&#x003b4;</bold> can be found by
requiring that the variance estimator match the linear model estimator of
Equation (<xref ref-type="disp-formula" rid="m26">4</xref>) in Section 3.0 when
complete randomization with <bold>V</bold> = <italic>p</italic>(1
&#x02212; <italic>p</italic>)<bold>I</bold> is used. With this requirement</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu93"/></disp-formula></p><p>Approximating the expectation of the ratio by the ratio of the expectations and
approximating <inline-formula><inline-graphic xlink:href="sim0031-3858-mu94.jpg" mimetype="image"/></inline-formula> by the product of
the expectations, <inline-formula><inline-graphic xlink:href="sim0031-3858-mu95.jpg" mimetype="image"/></inline-formula> is also an
approximately unbiased estimator of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu96.jpg" mimetype="image"/></inline-formula>.</p><p>Appendix A.2 shows for symmetrical 1 to 1 randomization methods, defined in
Section 2.1, that <inline-formula><inline-graphic xlink:href="sim0031-3858-mu97.jpg" mimetype="image"/></inline-formula> is unbiased
conditional on
<bold>&#x003b4;</bold><sup><bold><italic>&#x02032;</italic></bold></sup><bold>M</bold><bold>&#x003b4;</bold>
= <italic>c</italic>. The estimator <inline-formula><inline-graphic xlink:href="sim0031-3858-mu98.jpg" mimetype="image"/></inline-formula> is therefore
unconditionally unbiased for such randomization methods.</p></app><app id="app2"><title>Appendix A.2</title><p>For the properties of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu99.jpg" mimetype="image"/></inline-formula> conditional on
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> = <italic>c</italic>, it is
first necessary to evaluate <italic>E</italic>(<bold>&#x003b4;</bold> |
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> = <italic>c</italic>). In
general, this conditional expectation is not proportional to the vector
<bold>1</bold> even with <italic>E</italic>(<bold>&#x003b4;</bold>) =
<italic>p</italic><bold>1</bold>. An example for PBR in blocks of six for
treatments in a 2 to 1 ratio is given in Section 2.2.</p><p>In spite of potential bias issues with conditional inference with planned
unbalanced treatment allocation, <inline-formula><inline-graphic xlink:href="sim0031-3858-mu100.jpg" mimetype="image"/></inline-formula> is conditionally
unbiased with symmetrical 1 to 1 randomization, defined in Section 2.1, where
<italic>P</italic>(<bold>&#x003b4;</bold> =
<bold><italic>&#x003b4;</italic></bold><sub>0</sub>) =
<italic>P</italic>(<bold>&#x003b4;</bold> = <bold>1</bold> &#x02212;
<bold>&#x003b4;</bold><sub>0</sub>). To show this, note first that if
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> = <italic>c</italic> then
(<bold>1</bold> &#x02212;
<bold>&#x003b4;</bold>)<bold>&#x02032;</bold><bold>M</bold>(<bold>1</bold>
&#x02212; <bold>&#x003b4;</bold>) = <italic>c</italic>. Thus, let
{<bold>&#x003b4;</bold><sub><italic>ij</italic></sub>} denote
all treatment assignment sequences with <inline-formula><inline-graphic xlink:href="sim0031-3858-mu101.jpg" mimetype="image"/></inline-formula>, where
<bold>&#x003b4;</bold><sub><italic>i</italic>2</sub> = <bold>1</bold>
&#x02212; <bold>&#x003b4;</bold><sub><italic>i</italic>1</sub>. Also, let
<italic>p</italic><sub><italic>ij</italic></sub> denote the probability of
obtaining the sequence <bold>&#x003b4;</bold><sub><italic>ij</italic></sub>.
Because of symmetry, <italic>p</italic><sub><italic>i</italic>1</sub> =
<italic>p</italic><sub><italic>i</italic>2</sub>. By definition,</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu102"/></disp-formula></p><p>Hence, <inline-formula><inline-graphic xlink:href="sim0031-3858-mu103.jpg" mimetype="image"/></inline-formula> for all
<italic>c</italic>.</p><p>Let <inline-formula><inline-graphic xlink:href="sim0031-3858-mu104.jpg" mimetype="image"/></inline-formula> denote
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu105.jpg" mimetype="image"/></inline-formula>. Continuing with
symmetrical 1 to 1 randomization, it is easy to see that</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu106"/></disp-formula></p><p>where <inline-formula><inline-graphic xlink:href="sim0031-3858-mu107.jpg" mimetype="image"/></inline-formula>. Following the
approach in Appendix A.1,</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu108"/></disp-formula></p><p>is a conditionally unbiased estimator of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu109.jpg" mimetype="image"/></inline-formula>.</p></app><app id="app3"><title>Appendix B</title><p>Here, a proof is sketched of the asymptotic normality of
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu110.jpg" mimetype="image"/></inline-formula> under the
randomization model with <italic>E</italic><bold>&#x003b4;</bold> =
<italic>p</italic><bold>1</bold>. As in Section 2,
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu111.jpg" mimetype="image"/></inline-formula> is adjusted for
<bold>X</bold>, which has full column rank <italic>q</italic> and
<bold>1</bold> in its column space.</p><p>Intuitively, for reasonable randomization algorithms, treatment assignments for
very large <italic>n</italic> have almost no dependence on treatment assignments
for small <italic>n</italic>, so central limit theorems for sequences of random
variables that satisfy a &#x02018;strong mixing&#x02019; condition [<xref ref-type="bibr" rid="b37">37</xref>, <xref ref-type="bibr" rid="b38">38</xref>] should be helpful. However, the strong mixing conditions
are difficult to verify for randomization algorithms.</p><p>The approach taken here, then, is to approximate the sequence
&#x003b4;<sub>1</sub>,&#x003b4;<sub>2</sub>, &#x02026; with an asymptotically
equivalent triangular array
{&#x003b4;<sub><italic>n</italic>1</sub>,&#x003b4;<sub><italic>n</italic>2</sub>,
&#x02026; &#x003b4;<sub><italic>nn</italic></sub>}. The original
randomization scheme is applied within the array, except that treatment
assignments are based on only the most recent <italic>m</italic> patients, with
treatment assignments in earlier patients ignored. This makes the triangular
array <italic>m</italic>-dependent [<xref ref-type="bibr" rid="b38">38</xref>], and <italic>m</italic> will be allowed to increase with
<italic>n</italic>. Note that permuted-blocks randomization generates a
sequence of &#x003b4;s that is already <italic>m</italic>-dependent, where
<italic>m</italic> is the block size.</p><p>Because <inline-formula><inline-graphic xlink:href="sim0031-3858-mu112.jpg" mimetype="image"/></inline-formula> it suffices to
show the asymptotic normality of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu113.jpg" mimetype="image"/></inline-formula>. It will first be
shown that <bold>&#x003b4;&#x02032;My</bold><sub>0</sub> /
<italic>&#x0221a;n</italic> is asymptotically normal and then that
<bold>&#x003b4;&#x02032;M&#x003b4;</bold> / <italic>n</italic> &#x02192;
<sub>p</sub><italic>p</italic>(1 &#x02212; <italic>p</italic>), where
&#x02192; <sub>p</sub> denotes convergence in probability.</p><p>As before, let <bold>V</bold> = Var(<bold>&#x003b4;</bold>), with
(<italic>i</italic>, <italic>j</italic>) element
<italic>v</italic><sub><italic>ij</italic></sub>. Make the following
assumptions:</p><list list-type="simple"><list-item><p>(A1) <inline-formula><inline-graphic xlink:href="sim0031-3858-mu114.jpg" mimetype="image"/></inline-formula> as
<italic>n</italic> &#x02192; &#x0221e;.</p></list-item><list-item><p>(A2) Let (<italic>a</italic><sub><italic>n</italic>1</sub>, &#x02026;,
<italic>a</italic><sub><italic>nn</italic></sub>)<bold>&#x02032;</bold>
= <bold>a</bold><sub><italic>n</italic></sub> =
<bold>M</bold><bold>y</bold><sub>0</sub> and assume there is a
finite <italic>A</italic> with |
<italic>a</italic><sub><italic>ni</italic></sub> | &#x0003c;
<italic>A</italic> for all <italic>n</italic> and
<italic>i</italic>.</p></list-item><list-item><p>(A3) For all <italic>i</italic>, &#x003a3;<sub><italic>j</italic></sub> |
<italic>v</italic><sub><italic>ij</italic></sub> | &#x02192;
<italic>B</italic><sub><italic>i</italic></sub> as n &#x02192;
&#x0221e;, and there is a <italic>B</italic> with
<italic>B</italic><sub><italic>i</italic></sub> &#x0003c;
<italic>B</italic> for all <italic>i</italic>.</p></list-item></list><p>Let <bold>&#x003b4;</bold><sub><italic>n</italic></sub> =
(&#x003b4;<sub><italic>n</italic>1</sub>,&#x003b4;<sub><italic>n</italic>2</sub>,
&#x02026;
&#x003b4;<sub><italic>nn</italic></sub>)<sup><bold><italic>&#x02032;</italic></bold></sup>,
the vector of the <italic>m</italic>-dependent array elements, where
<italic>m</italic> is selected as the smallest integer less than or equal to
<italic>n</italic><sup>(0.5 &#x02212; &#x003f5;)</sup> for arbitrarily small
&#x003f5; &#x0003e; 0.</p><p>Now apply Berk's theorem [<xref ref-type="bibr" rid="b39">39</xref>]. His condition (i) on the uniform boundedness of
<italic>E</italic> |
<italic>a</italic><sub><italic>ni</italic></sub>&#x003b4;<sub><italic>ni</italic></sub>
| <sup>2 + <italic>r</italic></sup> applies for arbitrarily large
<italic>r</italic> owing to Assumption A2. His condition (ii) on the uniform
boundedness of
Var(<italic>a</italic><sub><italic>ni</italic></sub>&#x003b4;<sub><italic>ni</italic></sub>
+ &#x02026; +
<italic>a</italic><sub><italic>nj</italic></sub>&#x003b4;<sub><italic>nj</italic></sub>)
/ (<italic>j</italic> &#x02212; <italic>i</italic> + 1) for 1
<italic>&#x02264; i</italic> &#x0003c; <italic>j &#x02264; n</italic> is
satisfied because of both Assumptions A2 and A3. His condition (iii) on the
limit of
Var(<italic>a</italic><sub><italic>n</italic>1</sub>&#x003b4;<sub><italic>n</italic>1</sub>
+ &#x02026; +
<italic>a</italic><sub><italic>nn</italic></sub>&#x003b4;<sub><italic>nn</italic></sub>)
/ <italic>n</italic> follows from Assumption A1. Finally, his condition (iv) on
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu115.jpg" mimetype="image"/></inline-formula> is satisfied for
<italic>r</italic> &#x0003e; (1 &#x02212; &#x003f5;) / &#x003f5;, where &#x003f5;
was given above in the construction of the <italic>m</italic>-dependent array
<bold>&#x003b4;</bold><sub><italic>n</italic></sub>. It follows that
(<italic>a</italic><sub><italic>n</italic>1</sub>&#x003b4;<sub><italic>n</italic>1</sub>
+ &#x02026; +
<italic>a</italic><sub><italic>nn</italic></sub>&#x003b4;<sub><italic>nn</italic></sub>)
/ <italic>&#x0221a;n</italic> converges in distribution to
<italic>N</italic>(0,<italic>v</italic>).</p><p>Next, assume</p><list list-type="simple"><list-item><p>(A4) the maximum eigenvalue of <bold>V</bold>, denoted
<italic>&#x003bb;</italic><sub>max</sub>, is
<italic>o</italic>(<italic>n</italic>).</p></list-item></list><p>Using the inequality
<bold>l</bold><sup><bold><italic>&#x02032;</italic></bold></sup><bold>V</bold><bold>l</bold><italic>&#x02264;
&#x003bb;</italic><sub>max</sub> for any unit-length vector <bold>l</bold>,
it is then straightforward to show that <inline-formula><inline-graphic xlink:href="sim0031-3858-mu116.jpg" mimetype="image"/></inline-formula>. First, let
<bold>M</bold> = <bold>I</bold> &#x02212;
<bold>L</bold><bold>L&#x02032;</bold>, where <bold>L&#x02032;L</bold> =
<bold>I</bold><sub><italic>q</italic></sub>. Let
<bold>l</bold><sub><italic>i</italic></sub> denote the
<italic>i</italic><sup>th</sup> column of <bold>L</bold>, where without loss
of generality, <bold>l</bold><sub>1</sub> = <bold>1</bold> /
<italic>&#x0221a;n</italic>. Then</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu117"/></disp-formula></p><p>Now, <inline-formula><inline-graphic xlink:href="sim0031-3858-mu118.jpg" mimetype="image"/></inline-formula>, because
<italic>E</italic>(<bold>&#x003b4;</bold><sup><bold><italic>&#x02032;</italic></bold></sup><bold>1</bold>
/ <italic>n</italic>) = 0 and <inline-formula><inline-graphic xlink:href="sim0031-3858-mu119.jpg" mimetype="image"/></inline-formula>. The result
follows because for each <italic>i</italic> = 2, &#x02026;,
<italic>q</italic>, <inline-formula><inline-graphic xlink:href="sim0031-3858-mu120.jpg" mimetype="image"/></inline-formula> and
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu121.jpg" mimetype="image"/></inline-formula>. Thus,
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu122.jpg" mimetype="image"/></inline-formula> converges in
distribution to <italic>N</italic>(0,<italic>v</italic> /
{<italic>p</italic>(1 &#x02212;
<italic>p</italic>)}<sup>2</sup>).</p><p>Because <italic>v</italic> is unknown, practical application of the asymptotic
normality of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu123.jpg" mimetype="image"/></inline-formula> for tests and
confidence intervals requires a consistent estimator of <italic>v</italic> /
{<italic>p</italic>(1 &#x02212;
<italic>p</italic>)}<sup>2</sup>. It will now be shown that
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu124.jpg" mimetype="image"/></inline-formula> of Equation
(A1.3) provides one solution, but a further assumption is needed.</p><list list-type="simple"><list-item><p>(A5) <italic>&#x003bb;</italic><sub>max</sub>, the maximum eigenvalue of
<bold>V</bold>, is <italic>o</italic>(<italic>&#x0221a;n</italic>).
This is a stronger version of Assumption A4.</p></list-item></list><p>Now,</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu125"/></disp-formula></p><p>The pieces of this expression will be handled in turn, starting with the
denominator. As shown above, <inline-formula><inline-graphic xlink:href="sim0031-3858-mu126.jpg" mimetype="image"/></inline-formula>. Next, with
<bold>M</bold> = <bold>I</bold> &#x02212;
<bold>L</bold><bold>L&#x02032;</bold> as above,
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu127.jpg" mimetype="image"/></inline-formula>. The trace of
<bold>V</bold> is <italic>np</italic>(1 &#x02212; <italic>p</italic>) and
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu128.jpg" mimetype="image"/></inline-formula> is bounded
between 0 and <italic>q&#x003bb;</italic><sub>max</sub> / <italic>n</italic>,
which converges to zero by A5. Thus, <inline-formula><inline-graphic xlink:href="sim0031-3858-mu129.jpg" mimetype="image"/></inline-formula>. Continuing with
the denominator, <inline-formula><inline-graphic xlink:href="sim0031-3858-mu130.jpg" mimetype="image"/></inline-formula> from both A5 and
the convergence in probability of <bold>&#x003b4;&#x02032;M&#x003b4;</bold> /
<italic>n</italic>.</p><p>For the numerator of <inline-formula><inline-graphic xlink:href="sim0031-3858-mu131.jpg" mimetype="image"/></inline-formula>,
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu132.jpg" mimetype="image"/></inline-formula> by Assumption A1.
Next, <inline-formula><inline-graphic xlink:href="sim0031-3858-mu133.jpg" mimetype="image"/></inline-formula> and it will be
shown that <inline-formula><inline-graphic xlink:href="sim0031-3858-mu134.jpg" mimetype="image"/></inline-formula>, implying that
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu135.jpg" mimetype="image"/></inline-formula>. The following
repeatedly uses the inequality <bold>l&#x02032;Vl</bold><italic>&#x02264;
&#x003bb;</italic><sub>max</sub> for any unit-length vector <bold>l</bold>
and that <inline-formula><inline-graphic xlink:href="sim0031-3858-mu136.jpg" mimetype="image"/></inline-formula> for any
<bold>x</bold>.</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu137"/></disp-formula></p><p>which converges to 0 because of Assumptions A1 and A5. For the final term in the
numerator of the expression, <inline-formula><inline-graphic xlink:href="sim0031-3858-mu138.jpg" mimetype="image"/></inline-formula> converges in
distribution to a central normal distribution, so in absolute value</p><p><disp-formula><graphic xlink:href="sim0031-3858-mu139"/></disp-formula></p><p>which converges in probability to 0, completing the proof that
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu140.jpg" mimetype="image"/></inline-formula> converges to a
standard normal distribution.</p></app><app id="app4"><title>Appendix C</title><p>The dynamic randomization method of Section 5 that randomizes patients in a 2 to
1 ratio proceeds as follows. Determine the stratification variable values
<italic>s</italic><sub>1</sub> and <italic>s</italic><sub>2</sub> for the
current patient to be randomized and determine <italic>n</italic><sub>10</sub>,
<italic>n</italic><sub>11</sub>, and <italic>n</italic><sub>12</sub> for
previously randomized patients, where, for example,
<italic>n</italic><sub>11</sub> equals the number of the previously
randomized patients with Stratum 1 level equal to the level
<italic>s</italic><sub>1</sub> of the current patient who were randomized to
treatment level 1. Likewise, determine <italic>n</italic><sub>20</sub>,
<italic>n</italic><sub>21</sub>, and <italic>n</italic><sub>22</sub>. The
assignment probabilities for the current patient are determined by the balance
in these counts first for Stratum 1 and then for Stratum 2. If
<inline-formula><inline-graphic xlink:href="sim0031-3858-mu141.jpg" mimetype="image"/></inline-formula>, then the
treatment assignment probabilities depend on the pattern of the
<italic>n</italic><sub>10</sub>, <italic>n</italic><sub>11</sub>, and
<italic>n</italic><sub>12</sub> counts as follows:</p><list list-type="simple"><list-item><p>- With three unique values, the probabilities are, respectively, 0.75,
0.15, and 0.10 for the treatments associated with the minimum,
intermediate, and maximum treatment counts
<italic>n</italic><sub>1<italic>j</italic></sub></p></list-item><list-item><p>- With two values at the minimum count and one at the maximum, the
probabilities are 0.40 for each of the treatments associated with the
minimum count and 0.2 for the treatment associated with the maximum
count</p></list-item><list-item><p>- With one value at the minimum count and two values at the maximum, the
probabilities are 0.12 for each of the treatments associated with the
maximum count and 0.76 for the treatment associated with the minimum
count</p></list-item></list><p>If max(<italic>n</italic><sub>1<italic>j</italic></sub>) &#x02212;
min(<italic>n</italic><sub>1<italic>j</italic></sub>) = 0 then a
similar check on Stratum 2 counts is performed, with unequal treatment
assignment probabilities as above if there is imbalance. If there is balance of
counts for Stratum 2, then the treatment for the current patient is selected
from 0, 1, and 2 with equal probability.</p><p>To convert from 1 to 1 to 1 randomization to 2 to 1 randomization, patients
randomized to treatment 0 are given control treatment and patients randomized to
treatments 1 or 2 are given experimental.</p><p>The probabilities in the above algorithm were selected to match the conditional
treatment assignment probabilities of the stratified PBR in blocks of six in the
following sense. With complete randomization, the probability of assignment to
experimental treatment is 2/3 regardless of previous treatment assignments, so
the deviation from the target unconditional probability of 2/3 is zero. At the
other extreme is a deterministic scheme where a fixed one-third of the patients
are given control treatment and a fixed two-thirds are given experimental, so
the squared deviation from the target unconditional probability of 2/3 is (0
&#x02212; 2 / 3)<sup>2</sup> / 3 + 2(1 &#x02212; 2 / 3)<sup>2</sup> / 3
= 0.22. In the example of Section 5 the mean squared deviation as
estimated from the simulation is approximately 0.05 for both the stratified PBR
and the sequential method described above.</p></app></app-group><ref-list><title>References</title><ref id="b1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matts</surname><given-names>JP</given-names></name><name><surname>Lachin</surname><given-names>JM</given-names></name></person-group><article-title>Properties of permuted-block randomization in clinical
trials</article-title><source>Controlled Clinical Trials</source><year>1988</year><volume>9</volume><fpage>327</fpage><lpage>344</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1016/0197-2456(88)90047-5">10.1016/0197-2456(88)90047-5</ext-link></comment><pub-id pub-id-type="pmid">3203524</pub-id></element-citation></ref><ref id="b2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Efron</surname><given-names>B</given-names></name></person-group><article-title>Forcing a sequential experiment to be balanced</article-title><source>Biometrika</source><year>1971</year><volume>58</volume><fpage>403</fpage><lpage>417</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1093/biomet/58.3.403">10.1093/biomet/58.3.403</ext-link></comment></element-citation></ref><ref id="b3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pocock</surname><given-names>SJ</given-names></name><name><surname>Simon</surname><given-names>R</given-names></name></person-group><article-title>Sequential treatment assignment with balancing for prognostic
factors in the controlled clinical tria</article-title><source>Biometrics</source><year>1975</year><volume>31</volume><fpage>103</fpage><lpage>115</lpage><pub-id pub-id-type="pmid">1100130</pub-id></element-citation></ref><ref id="b4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>LJ</given-names></name></person-group><article-title>The application of an urn model to the design of sequential
controlled trials</article-title><source>Journal of the American Statistical Association</source><year>1978</year><volume>73</volume><fpage>559</fpage><lpage>563</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1080/01621459.1978.10480054">10.1080/01621459.1978.10480054</ext-link></comment></element-citation></ref><ref id="b5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Borm</surname><given-names>GF</given-names></name><name><surname>Hoogendoorn</surname><given-names>EH</given-names></name><name><surname>den Heijer</surname><given-names>M</given-names></name><name><surname>Zielhuis</surname><given-names>GA</given-names></name></person-group><article-title>Sequential balancing: A simple method for treatment allocation in
clinical trials</article-title><source>Contemporary Clinical Trials</source><year>2005</year><volume>26</volume><fpage>637</fpage><lpage>645</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1016/j.cct.2005.09.002">10.1016/j.cct.2005.09.002</ext-link></comment><pub-id pub-id-type="pmid">16226925</pub-id></element-citation></ref><ref id="b6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Han</surname><given-names>B</given-names></name><name><surname>Enas</surname><given-names>NH</given-names></name><name><surname>McEntegert</surname><given-names>D</given-names></name></person-group><article-title>Randomization by minimization for unbalanced treatment
allocation</article-title><source>Statistics in Medicine</source><year>2009</year><volume>28</volume><fpage>3329</fpage><lpage>3346</lpage><pub-id pub-id-type="pmid">19739238</pub-id></element-citation></ref><ref id="b7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Su</surname><given-names>Z</given-names></name></person-group><article-title>Balancing multiple baseline characteristics in randomized
clinical trials</article-title><source>Contemporary Clinical Trials</source><year>2011</year><volume>32</volume><fpage>547</fpage><lpage>550</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1016/j.cct.2011.03.004">10.1016/j.cct.2011.03.004</ext-link></comment><pub-id pub-id-type="pmid">21382510</pub-id></element-citation></ref><ref id="b8"><label>8</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Kempthorne</surname><given-names>O</given-names></name></person-group><source>The Design and Analysis of Experiments</source><year>1975</year><publisher-loc>NY</publisher-loc><publisher-name>Krieger</publisher-name></element-citation></ref><ref id="b9"><label>9</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Scheff&#x000e9;</surname><given-names>H</given-names></name></person-group><source>The Analysis of Variance</source><year>1959</year><publisher-loc>NY</publisher-loc><publisher-name>Wiley</publisher-name></element-citation></ref><ref id="b10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelder</surname><given-names>JA</given-names></name></person-group><article-title>The analysis of randomized experiments with orthogonal block
structure. I. Block structure and the null analysis of
variance</article-title><source>Proceedings of the Royal Society of London A</source><year>1965</year><volume>283</volume><fpage>147</fpage><lpage>162</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1098/rspa.1965.0012">10.1098/rspa.1965.0012</ext-link></comment></element-citation></ref><ref id="b11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelder</surname><given-names>JA</given-names></name></person-group><article-title>The analysis of randomized experiments with orthogonal block
structure. II. Treatment structure and the general analysis of
variance</article-title><source>Proceedings of the Royal Society of London A</source><year>1965</year><volume>283</volume><fpage>63</fpage><lpage>178</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1098/rspa.1965.0013">10.1098/rspa.1965.0013</ext-link></comment></element-citation></ref><ref id="b12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smythe</surname><given-names>RT</given-names></name><name><surname>Wei</surname><given-names>LJ</given-names></name></person-group><article-title>Significance tests with restricted randomization
design</article-title><source>Biometrika</source><year>1983</year><volume>70</volume><fpage>496</fpage><lpage>500</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1093/biomet/70.2.496">10.1093/biomet/70.2.496</ext-link></comment></element-citation></ref><ref id="b13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Smith</surname><given-names>RL</given-names></name></person-group><article-title>Sequential treatment allocation using biased coin
designs</article-title><source>Journal of the Royal Statistical Society, B</source><year>1984</year><volume>46</volume><fpage>519</fpage><lpage>543</lpage></element-citation></ref><ref id="b14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>LJ</given-names></name><name><surname>Smythe</surname><given-names>RT</given-names></name><name><surname>Smith</surname><given-names>RL</given-names></name></person-group><article-title>K-treatment comparisons with restricted randomization rules in
clinical trials</article-title><source>The Annals of Statistics</source><year>1986</year><volume>14</volume><fpage>265</fpage><lpage>274</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1214/aos/1176349854">10.1214/aos/1176349854</ext-link></comment></element-citation></ref><ref id="b15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Shao</surname><given-names>J</given-names></name><name><surname>Yu</surname><given-names>X</given-names></name><name><surname>Zhong</surname><given-names>B</given-names></name></person-group><article-title>A theory for testing hypotheses under covariate-adaptive
randomization</article-title><source>Biometrika</source><year>2010</year><volume>97</volume><fpage>347</fpage><lpage>360</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1093/biomet/asq014">10.1093/biomet/asq014</ext-link></comment></element-citation></ref><ref id="b16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenkranz</surname><given-names>GK</given-names></name></person-group><article-title>The impact of randomization on the analysis of clinical
trials</article-title><source>Statistics in Medicine</source><year>2011</year><volume>30</volume><fpage>3475</fpage><lpage>3487</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1002/sim.4376">10.1002/sim.4376</ext-link></comment><pub-id pub-id-type="pmid">21953285</pub-id></element-citation></ref><ref id="b17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wei</surname><given-names>LJ</given-names></name><name><surname>Lachin</surname><given-names>JM</given-names></name></person-group><article-title>Properties of the urn randomization in clinical
trials</article-title><source>Controlled Clinical Trials</source><year>1988</year><volume>9</volume><fpage>345</fpage><lpage>364</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1016/0197-2456(88)90048-7">10.1016/0197-2456(88)90048-7</ext-link></comment><pub-id pub-id-type="pmid">3203525</pub-id></element-citation></ref><ref id="b18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Halpern</surname><given-names>J</given-names></name><name><surname>Brown</surname><given-names>BW</given-names><suffix>Jr</suffix></name></person-group><article-title>Sequential treatment allocation procedures in clinical
trials&#x02014;with particular attention to the analysis of results for the
biased coin design</article-title><source>Statistics in Medicine</source><year>1986</year><volume>5</volume><fpage>211</fpage><lpage>229</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1002/sim.4780050303">10.1002/sim.4780050303</ext-link></comment><pub-id pub-id-type="pmid">3738289</pub-id></element-citation></ref><ref id="b19"><label>19</label><element-citation publication-type="journal"><collab>Committee for Proprietary Medicinal Products</collab><article-title>Points to consider on adjustment for baseline
covariates</article-title><source>Statistics in Medicine</source><year>2004</year><volume>23</volume><fpage>701</fpage><lpage>709</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1002/sim.1647">10.1002/sim.1647</ext-link></comment><pub-id pub-id-type="pmid">14981670</pub-id></element-citation></ref><ref id="b20"><label>20</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kuznetsova</surname><given-names>OM</given-names></name><name><surname>Tymofyeyev</surname><given-names>Y</given-names></name></person-group><article-title>Brick tunnel randomization for unequal allocation to two or more
treatment groups</article-title><source>Statistics in Medicine</source><year>2011</year><volume>30</volume><fpage>812</fpage><lpage>824</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1002/sim.4167">10.1002/sim.4167</ext-link></comment><pub-id pub-id-type="pmid">21432876</pub-id></element-citation></ref><ref id="b21"><label>21</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cox</surname><given-names>DR</given-names></name></person-group><article-title>A remark on randomization in clinical trials</article-title><source>Utilitas Mathematica</source><year>1982</year><volume>21</volume><fpage>245</fpage><lpage>252</lpage></element-citation></ref><ref id="b22"><label>22</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McHugh</surname><given-names>R</given-names></name><name><surname>Matts</surname><given-names>J</given-names></name></person-group><article-title>Post-stratification in the randomized clinical
trial</article-title><source>Biometrics</source><year>1983</year><volume>39</volume><fpage>217</fpage><lpage>225</lpage><pub-id pub-id-type="pmid">6871350</pub-id></element-citation></ref><ref id="b23"><label>23</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>McEntegert</surname><given-names>DJ</given-names></name></person-group><article-title>The pursuit of balance using stratified and dynamic randomization
techniques: An overview</article-title><source>Drug Information Journal</source><year>2003</year><volume>37</volume><fpage>293</fpage><lpage>308</lpage></element-citation></ref><ref id="b24"><label>24</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Oden</surname><given-names>NL</given-names></name><name><surname>McIntosh</surname><given-names>MJ</given-names></name></person-group><article-title>Exact moments and probabilities for Wei's urn
randomization model</article-title><source>Statistics &#x00026; Probability Letters</source><year>2006</year><volume>76</volume><fpage>1694</fpage><lpage>1700</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1016/j.spl.2006.04.012">10.1016/j.spl.2006.04.012</ext-link></comment></element-citation></ref><ref id="b25"><label>25</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Markaryan</surname><given-names>T</given-names></name><name><surname>Rosenberger</surname><given-names>WF</given-names></name></person-group><article-title>Exact properties of Efron's biased coin randomization
procedure</article-title><source>The Annals of Statistics</source><year>2010</year><volume>38</volume><fpage>1546</fpage><lpage>1567</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1214/09-AOS758">10.1214/09-AOS758</ext-link></comment></element-citation></ref><ref id="b26"><label>26</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hollander</surname><given-names>M</given-names></name><name><surname>Pe&#x000f1;a</surname><given-names>E</given-names></name></person-group><article-title>Nonparametric tests under restricted treatment-assignment
rules</article-title><source>Journal of the American Statistical Association</source><year>1988</year><volume>83</volume><fpage>1144</fpage><lpage>1151</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1080/01621459.1988.10478712">10.1080/01621459.1988.10478712</ext-link></comment></element-citation></ref><ref id="b27"><label>27</label><element-citation publication-type="journal"><article-title>International Conference on Harmonisation: Guidance on
statistical principles for clinical trials</article-title><source>Federal Register</source><year>1998</year><volume>63</volume><issue>179</issue><fpage>49583</fpage><lpage>49598</lpage><comment>Available from: <ext-link ext-link-type="uri" xlink:href="http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM073137.pdf">http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM073137.pdf</ext-link>
(Accessed 2 May 2012)</comment><pub-id pub-id-type="pmid">10185190</pub-id></element-citation></ref><ref id="b28"><label>28</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachin</surname><given-names>JM</given-names></name></person-group><article-title>Properties of simple randomization in clinical
trials</article-title><source>Controlled Clinical Trials</source><year>1988</year><volume>9</volume><fpage>312</fpage><lpage>326</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1016/0197-2456(88)90046-3">10.1016/0197-2456(88)90046-3</ext-link></comment><pub-id pub-id-type="pmid">3203523</pub-id></element-citation></ref><ref id="b29"><label>29</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heritier</surname><given-names>S</given-names></name><name><surname>Gebski</surname><given-names>V</given-names></name><name><surname>Pillai</surname><given-names>P</given-names></name></person-group><article-title>Dynamic balancing randomization in controlled clinical
trials</article-title><source>Statistics in Medicine</source><year>2005</year><volume>24</volume><fpage>3729</fpage><lpage>3741</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1002/sim.2421">10.1002/sim.2421</ext-link></comment><pub-id pub-id-type="pmid">16320277</pub-id></element-citation></ref><ref id="b30"><label>30</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Proschan</surname><given-names>M</given-names></name><name><surname>Brittain</surname><given-names>E</given-names></name><name><surname>Kammerman</surname><given-names>L</given-names></name></person-group><article-title>Minimize the use of minimization with unequal
allocation</article-title><source>Biometrics</source><year>2011</year><volume>67</volume><fpage>1135</fpage><lpage>1141</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1111/j.1541-0420.2010.01545.x">10.1111/j.1541-0420.2010.01545.x</ext-link></comment><pub-id pub-id-type="pmid">21281276</pub-id></element-citation></ref><ref id="b31"><label>31</label><element-citation publication-type="other"><comment>Endocrinologic and Metabolic Drugs Advisory Committee, October 21, 2008
(Meeting ID: 2008-4389). Available from: <ext-link ext-link-type="uri" xlink:href="http://www.fda.gov/ohrms/dockets/ac/cder08.html">http://www.fda.gov/ohrms/dockets/ac/cder08.html</ext-link>\#EndocrinologicMetabolic
(Accessed 2 May 2012)</comment></element-citation></ref><ref id="b32"><label>32</label><element-citation publication-type="book"><person-group person-group-type="author"><name><surname>Rosenberger</surname><given-names>WF</given-names></name><name><surname>Lachin</surname><given-names>JM</given-names></name></person-group><source>Randomization in Clinical Trials: Theory and Practice</source><year>2002</year><publisher-loc>New York</publisher-loc><publisher-name>Wiley</publisher-name></element-citation></ref><ref id="b33"><label>33</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Simon</surname><given-names>R</given-names></name></person-group><article-title>Restricted randomization designs in clinical
trials</article-title><source>Biometrics</source><year>1979</year><volume>35</volume><fpage>503</fpage><lpage>512</lpage><pub-id pub-id-type="pmid">486683</pub-id></element-citation></ref><ref id="b34"><label>34</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kempthorne</surname><given-names>O</given-names></name></person-group><article-title>Why randomize?</article-title><source>Journal of Statistical Planning and Inference</source><year>1977</year><volume>1</volume><fpage>1</fpage><lpage>25</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1016/0378-3758(77)90002-7">10.1016/0378-3758(77)90002-7</ext-link></comment></element-citation></ref><ref id="b35"><label>35</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lachin</surname><given-names>JM</given-names></name></person-group><article-title>Statistical properties of randomization in clinical
trials</article-title><source>Controlled Clinical Trials</source><year>1988</year><volume>9</volume><fpage>289</fpage><lpage>311</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1016/0197-2456(88)90045-1">10.1016/0197-2456(88)90045-1</ext-link></comment><pub-id pub-id-type="pmid">3060315</pub-id></element-citation></ref><ref id="b36"><label>36</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gadbury</surname><given-names>GL</given-names></name></person-group><article-title>Randomization inference and bias in standard
errors</article-title><source>The American Statistician</source><year>2001</year><volume>55</volume><fpage>310</fpage><lpage>313</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1198/000313001753272268">10.1198/000313001753272268</ext-link></comment></element-citation></ref><ref id="b37"><label>37</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rosenblatt</surname><given-names>M</given-names></name></person-group><article-title>A central limit theorem and a strong mixing
condition</article-title><source>Proceedings of the National Academy of Sciences USA</source><year>1956</year><volume>42</volume><fpage>43</fpage><lpage>47</lpage></element-citation></ref><ref id="b38"><label>38</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Serfling</surname><given-names>RJ</given-names></name></person-group><article-title>Contributions to central limit theory for dependent
variables</article-title><source>The Annals of Mathematical Statistics</source><year>1968</year><volume>39</volume><fpage>1158</fpage><lpage>1175</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1214/aoms/1177698240">10.1214/aoms/1177698240</ext-link></comment></element-citation></ref><ref id="b39"><label>39</label><element-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Berk</surname><given-names>KN</given-names></name></person-group><article-title>A central limit theorem for <italic>m</italic>-dependent random
variables with unbounded <italic>m</italic></article-title><source>The Annals of Probability</source><year>1974</year><volume>1</volume><fpage>352</fpage><lpage>354</lpage><comment>DOI: <ext-link ext-link-type="doi" xlink:href="10.1214/aop/1176996992">10.1214/aop/1176996992</ext-link></comment></element-citation></ref></ref-list></back></article>